PTC Therapeutics, Inc.

ISIN US69366J2006

 | 

WKN A1W0MW

Market cap (in EUR)
5,298 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 5,298 m
EPS, EUR 7.75
P/B ratio -
P/E ratio 9.1
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 746 m
Net income, EUR -336 m
Profit margin -45.03%

What ETF is PTC Therapeutics, Inc. in?

There are 4 ETFs which contain PTC Therapeutics, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of PTC Therapeutics, Inc. is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.47%
Equity
United States
Health Care
Biotech
45
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
486
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
27
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.08%
Equity
United States
Small Cap
178
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.